+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Nicotine Gum Market Size, Share & Trends Analysis Report By Type (2 mg and 4 mg), By Distribution Channel (Pharmacies, Supermarkets & Hypermarkets, and Online Stores. By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 101 Pages
  • June 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5988527
The Asia Pacific Nicotine Gum Market is projected to witness market growth of 6.1% CAGR during the forecast period (2024-2031). In the year 2022, the Asia Pacific market's volume surged to 8.80 million units (100pcs. Per pack), showcasing a growth of 14.8% (2020-2023).

Supermarkets and hypermarkets serve as significant distribution channels in the nicotine gum market, offering wide accessibility and convenience to consumers. These large retail outlets stock a variety of nicotine gum products, catering to different strengths and flavors, making it easier for customers to find suitable options for smoking cessation. Thus, the China market registered a volume of 991.80 thousand units in 2023.



The China market dominated the Asia Pacific Nicotine Gum Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $122.7 million by 2031. The Japan market is registering a CAGR of 5.4% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.8% during (2024 - 2031)
Many governments and healthcare authorities endorse nicotine gum as part of comprehensive smoking cessation programs. Healthcare providers often recommend nicotine gum through healthcare systems, pharmacies, and online platforms. Government subsidies, reimbursement programs, and inclusion in public health initiatives further support its adoption by making it more accessible and affordable for smokers.

Nicotine gum appeals to smokers who prefer self-directed methods for quitting smoking. Unlike prescription medications or nicotine patches that require healthcare provider involvement, nicotine gum is available over the counter in many countries. This accessibility allows smokers to initiate and manage their quitting process independently, which aligns with the trend toward consumer empowerment in healthcare decisions.

The focus on smoking control in China drives market growth for nicotine gum by creating a conducive environment for manufacturers to innovate and expand their product offerings. There is a push towards developing new formulations, improving taste profiles, and enhancing the effectiveness of nicotine gum, which appeals to a larger segment of the population seeking effective smoking cessation solutions. Therefore, increasing smoking control in the region is propelling the market's growth.

List of Key Companies Profiled

  • Johnson & Johnson
  • Novartis AG
  • ITC Limited
  • Cipla Limited
  • Perrigo Company PLC
  • Philip Morris International, Inc.
  • ALCHEM INTERNATIONAL PVT. LTD.
  • Alkalon A/S

Market Report Segmentation

By Type (Volume, thousand units (100pcs. Per pack), USD Billion, 2020-2031)
  • 2 mg
  • 4 mg
By Distribution Channel (Volume, thousand units (100pcs. Per pack), USD Billion, 2020-2031)
  • Pharmacies
  • Supermarkets & Hypermarkets
  • Online Stores
By Country (Volume, thousand units (100pcs. Per pack), USD Billion, 2020-2031)
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Nicotine Gum Market, by Type
1.4.2 Asia Pacific Nicotine Gum Market, by Distribution Channel
1.4.3 Asia Pacific Nicotine Gum Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Asia Pacific Nicotine Gum Market by Type
4.1 Asia Pacific 2 mg Market by Country
4.2 Asia Pacific 4 mg Market by Country
Chapter 5. Asia Pacific Nicotine Gum Market by Distribution Channel
5.1 Asia Pacific Pharmacies Market by Country
5.2 Asia Pacific Supermarkets & Hypermarkets Market by Country
5.3 Asia Pacific Online Stores Market by Country
Chapter 6. Asia Pacific Nicotine Gum Market by Country
6.1 China Nicotine Gum Market
6.1.1 China Nicotine Gum Market by Type
6.1.2 China Nicotine Gum Market by Distribution Channel
6.2 Japan Nicotine Gum Market
6.2.1 Japan Nicotine Gum Market by Type
6.2.2 Japan Nicotine Gum Market by Distribution Channel
6.3 India Nicotine Gum Market
6.3.1 India Nicotine Gum Market by Type
6.3.2 India Nicotine Gum Market by Distribution Channel
6.4 South Korea Nicotine Gum Market
6.4.1 South Korea Nicotine Gum Market by Type
6.4.2 South Korea Nicotine Gum Market by Distribution Channel
6.5 Singapore Nicotine Gum Market
6.5.1 Singapore Nicotine Gum Market by Type
6.5.2 Singapore Nicotine Gum Market by Distribution Channel
6.6 Malaysia Nicotine Gum Market
6.6.1 Malaysia Nicotine Gum Market by Type
6.6.2 Malaysia Nicotine Gum Market by Distribution Channel
6.7 Rest of Asia Pacific Nicotine Gum Market
6.7.1 Rest of Asia Pacific Nicotine Gum Market by Type
6.7.2 Rest of Asia Pacific Nicotine Gum Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Alkalon A/S
7.1.1 Company Overview
7.2 Alchem International Pvt. Ltd.
7.2.1 Company Overview
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental & Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 SWOT Analysis
7.4 Novartis AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 ITC Limited
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Cipla Limited
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Perrigo Company PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Philip Morris International Inc.
7.8.1 Company Overview

Companies Mentioned

  • Johnson & Johnson
  • Novartis AG
  • ITC Limited
  • Cipla Limited
  • Perrigo Company PLC
  • Philip Morris International, Inc.
  • ALCHEM INTERNATIONAL PVT. LTD.
  • Alkalon A/S

Methodology

Loading
LOADING...